QUANTRX BIOMEDICAL CORP (QTXB) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues [+]	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
Products							0.0	0.0
Revenue growth				-100.0%		-100.0%	-93.6%	-60.2%
Cost of goods sold	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0
Gross profit	0.0	0.0	-0.1	-0.1	0.2	-0.1	0.0	0.0
Gross margin					49.1%		-5394.9%	18.6%
Selling, general and administrative [+]	0.0	0.1	0.1	0.2	0.2	0.1	0.3	0.4
Sales and marketing	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1
General and administrative	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.3
Other selling, general and administrative	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1
Research and development							0.0	0.1
Equity in earnings
Other operating expenses			-0.2	-0.3		-0.2	0.0	0.0
EBITDA [+]					0.0	-0.1	-0.3	-0.4
EBITDA growth	-28.4%	-399.2%	-51.9%	169.4%	-130.3%	-85.2%	-22.2%	59.7%
EBITDA margin					4.8%		-223746.2%	-18454.4%
Depreciation and amortization					0.0	0.0	0.0	0.0
EBIT [+]	0.0	-0.1	0.0	0.0	0.0	-0.1	-0.4	-0.5
EBIT growth	-28.4%	-399.2%	-51.9%	781.7%	-108.1%	-83.6%	-21.7%	58.0%
EBIT margin					1.5%		-229941.7%	-18852.1%
Non-recurring items [+]			0.2	0.3	0.2	0.1		0.0
Asset impairment			0.2	0.3	0.2	0.1		0.0
Interest expense, net [+]	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1
Interest expense	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1
Interest income				0.0				0.0
Other income (expense), net [+]		0.0	-0.2	-0.3	1.3	-0.1	0.0	-0.3
Amortization of debt discount premium					0.0		0.0	-0.2
Gain (loss) on sale of assets				-0.2	1.4
Gain (loss) on debt retirement		0.0		0.1	0.0	0.0	0.1	-0.1
Gain (loss) on derivative instruments				0.1		0.0	0.0
Other	-0.2	-0.2	-0.4	-0.5	1.0	-0.3	-0.1	-0.4
Pre-tax income	-0.3	-0.3	-0.6	-0.7	0.9	-0.4	-0.5	-0.8
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-0.3	-0.3	-0.6	-0.7	0.9	-0.4	-0.5	-0.8
Net margin					268.0%		-299859.0%	-34032.3%

Basic EPS [+]	$0.00	$0.00	($0.01)	($0.01)	$0.01	($0.01)	($0.01)	($0.01)
Growth	2.9%	-59.4%	-15.6%	-184.8%	-306.0%	-23.4%	-50.2%	106.3%
Diluted EPS [+]	$0.00	$0.00	($0.01)	($0.01)	$0.01	($0.01)	($0.01)	($0.01)
Growth	2.9%	-59.4%	-15.6%	-240.5%	-224.3%	-23.4%	-50.2%	106.3%

Shares outstanding (basic) [+]	78.7	78.7	78.7	78.7	78.7	74.2	66.8	58.8
Growth	0.0%	0.0%	0.0%	0.0%	6.0%	11.1%	13.7%	11.9%
Shares outstanding (diluted) [+]	78.7	78.7	78.7	78.7	130.4	74.2	66.8	58.8
Growth	0.0%	0.0%	0.0%	-39.7%	75.7%	11.1%	13.7%	11.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.